From Our Partners
Wednesday, June 29, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biodetection

UC Davis Develops New Latent TB Testing Method

by Global Biodefense Staff
May 24, 2012

Engineers at UC Davis have developed a microfluidic chip to test for latent tuberculosis (TB) which aims to be more reliable, faster and less expensive than current testing options available.

According to the Centers for Disease Control and Prevention, an estimated 1.5 million people worldwide are killed by the disease annually, and nearly one-third of the world’s population is infected with latent TB.  Those with latent TB are at risk for the tuberculosis bacteria to become active if their immune system is compromised.

Current tests for latent TB are based on detecting interferon-gamma, a disease-fighting chemical made by cells of the immune system.  The researchers at UC Davis took a novel approach to detection utilizing a gold wafer coated with short pieces of single-strand DNA segments known to “stick” specifically to interferon-gamma. Then using a chip that has tiny channels for blood samples, they mounted the wafer. If interferon-gamma is in a blood sample, it sticks to the DNA, prompting an electrical signal that can be read by a clinician. High interferon-gamma levels would be correlated to diagnose latent TB.

Such a device would allow rapid results and circumvent the need to send samples out to a laboratory. “Our assay is cheaper, reusable, and gives results in real time,” said Ying Liu, a UC Davis Department of Biomedical Engineering research specialist working with Professor Alexander Revzin on the project.

The researchers have filed a patent application for the technology. Moving forward, the team plans to incorporate the microfluidic sensor and electronic readout onto a single chip and then work towards FDA approval and commercialization of the diagnostic device.

Image provided courtesy of Ying Liu, UC Davis

From Our Partners
Tags: Chemical DetectionTuberculosis

Related Posts

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps
Outbreak News

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

June 22, 2022
Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies
Biosurveillance

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

June 22, 2022
Influenza Research
Biodetection

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022
BARDA and JPEO-CBRND Back Cepheid’s Multiplex Test for Influenza, SARS-CoV2 and RSV
Health Security

Resurgent COVID-19, Flu and Other Viruses are Pushing New Zealand’s Health System to the Limit

June 2, 2022
Load More

Latest News

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

June 22, 2022
Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

June 22, 2022
UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Influenza Research

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC